ZMT, represented by CTO Myles Capstick and CEO Michael Oberle, hosted a 2-day meeting – December 4 and 5, 2017 – of the researchers working on the PerfusImaging project to review progress and plan future research tasks.
PerfusImaging, short for "Metrology for Multi-Modality Imaging of Impaired Tissue Perfusion", is a project organized under the auspices of the European Association of National Metrology Institutes (EURAMET). The project is funded by Horizon 2020, the EU Framework Programme for Research and Innovation, awarded to a proposal in response to a call of the European Metrology Programme for Innovation and Research (EMPIR). The international consortium is coordinated by Prof. Tobias Schäffter, head of the Division of Medical Physics and Metrological Information Technology of Germany's National Metrology Institute (PTB), with participants from King's College London (KCL) and the National Physical Laboratory (NPL) in the UK, France's National Laboratory of Metrology and Testing (LNE), the National Metrology Institute (VSL) in the Netherlands, and the Turku University Hospital (TYKS) in Finland.
The aim of the project is to develop new standards and tools to use for validating emerging techniques for identifying those at risk of cardiovascular disease. Patients with intermediate risk of cardiovascular disease have a better chance of survival if they are offered appropriate treatment at an earlier stage, and there is an urgent need for reliable diagnostic tests for identification of such patients. Accurate measurement of perfusion in the heart, which can indicate where blood supply is inadequate, could be well-suited but are currently possible only through invasive catheter-based diagnosis. Medical imaging is an alternative, non-invasive approach to the measurement of perfusion, however, the results can vary widely as a function of imaging technique used. It is hoped that the physical standards and data analysis tools for evaluation of imaging techniques developed under PerfusImaging will lead to diganostic protocols for early diagnosis of cardiovascular disease.